A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)

Clinical trial NCT02660944 · COMPLETED

Trial details

NCT number: NCT02660944
Sponsor: Resolve Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2016-01-03
Primary completion: 2020-05-28
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.